Filter posts

BIO’S Spring IPCC Conference Registration is Now OPEN! With Special Offer for First Time In-House ...

Pack your bags patent practitioners – We’re heading back to the French Quarter. Registration for BIO’s …

The Value of Academic-Industry Partnerships

More than a decade ago, the NIH Roadmap and the FDA Critical Path Report brought significant public …

Former Senator Kyl: Abuse of the Patent Review Hurts American Innovation

Earlier this week The Hill ran an op-ed by Former Arizona Senator Jon Kyl in …

#BIF17: Turning the Tide on Antimicrobial Resistance

It’s no secret that antimicrobial resistance (AMR) is one of the most serious public health …

BIO to Senate Judiciary: Stop Abuses at PTO

Gamesmanship of the United States Patent and Trademark Office’s (PTO) Inter Partes Review (IPR) process …

Double Jeopardy at the PTO Threatens Healthcare Innovation

There has been no shortage of commentary related to the efforts of Allergan to shield …

ICYMI: Patent Abuse Is Undermining American Health Care

The pharmaceutical company Allergan recently announced a decision to transfer the intellectual property rights of …

Strong Public Policy is the Bedrock of Biotech Economic Growth

As noted in the recently-released 2017 BIO publication Bioscience Innovation in the States: Job Creation …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

BIO Fall IPCC Meeting: Special Offer for First Time In-House Attendees!

Are you a patent practitioner at a biotech company? Is your in-house IP group small, …